|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.1399 - 1.1800|
|52 Week Range||1.1100 - 5.8000|
|Beta (3Y Monthly)||2.89|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2019 - Nov 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, announced today its MariMed Hemp division will exhibit its Florance™ brand of CBD products at Natural Products Expo East being held at the Baltimore Convention Center on September 11-14, 2019. MariMed invites attendees to stop by the company’s booth #4902 where it will exhibit its full line of Florance Hemp CBD products in several categories, including health, beauty, pain and sports. Dr. Jokubas Zirbucus, MariMed’s chief innovation officer and one of the founders of the Florance brand, has organized an experienced medical team to develop new formulations that produce consistent and satisfying results for consumers and patients.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a special permit to allow its Panacea Wellness™ dispensary in Middleborough to merchandise cannabis products under the Massachusetts adult use program. It will now proceed at the Cannabis Control Commission (CCC) for adult use final approval. The dispensary has already received town approval for medical use.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a certificate of occupancy from the city of New Bedford, Massachusetts for its new cannabis cultivation and manufacturing facility. “ARL Healthcare, our Massachusetts cannabis licensed subsidiary, will now schedule its final state inspection to be cleared to commence full operations of its cultivation, production and dispensary,” said Bob Fireman, MariMed’s CEO. The New Bedford manufacturing facility is part of a 137,000 sf building situated on 17 acres providing for future growth and expansion.
The OTCQX® Best Market is top tier of OTC Markets; provides exchange-quality trading experience with superior information availability for investorsMRMD to begin trading on.
NORWOOD, Mass., Aug. 12, 2019 -- MariMed Inc. (MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, reported record results for both the.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has engaged CMA, a leading capital markets advisory firm, to lead a new strategic investor relations program. MariMed has rapidly emerged as a premier seed-to-sale cannabis and hemp multi-state operator, providing highest quality products for enhanced customer and patient wellness, state-of-the-art facilities, and recognized brands. The company also owns a significant percentage of GenCanna Global USA, Inc., the Kentucky-based, national leader in cultivation and production of seed-to-sale cGMP quality CBD derived from hemp.
MariMed Hemp, a subsidiary of MariMed, Inc. (MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, has launched the Hemp Engine™, a turnkey retail marketing platform for the fast-growing CBD sector. The platform supports sales and marketing decisions for a wide range of CBD products based on quality, popularity and price point, allowing distributors and retailers to maximize returns and increase sales efficiency. Co-developed with Sprout™, the leading CRM provider to the cannabis industry, the platform is driven by proprietary data and technology.
Under the terms of the agreements, MariMed is licensed to manufacture and distribute the Binske portfolio of products in seven states: Illinois, Ohio, Massachusetts, Rhode Island, Maryland, Delaware, and Maine, adding substantially to the availability of Binske brands, which are currently licensed in Colorado, Nevada, Florida, and California. The Binske brands include a variety of consumer options, including concentrates, edibles, vaporizers, and topicals. Ryan Crandall, MariMed's Chief Product Officer and SVP Sales, stated, "Binske is a popular brand in Colorado and Nevada, and we are enthusiastic about the potential of its products in the markets where we operate. Binske will be an exciting addition to the diverse portfolio of seven brands MariMed currently owns and licenses, such as Betty's Eddies™, Nature’s Heritage™ and Kalm Fusion™, among others.
MariMed Inc. (MRMD), a leading multi-state cannabis operator focused on health and wellness, announced the appointment of Mr. Jonathan Rider to the newly created position of Chief Information Officer, effective immediately. Mr. Rider brings over 25 years of technology experience to MariMed and has held multiple senior leadership positions across various industries, with a consistent focus on supporting global business operations.
MariMed Inc. (MRMD) a leading multi-state cannabis operator focused on health and wellness, today announced that its MariMed Hemp division will be hosting an educational seminar for medical practitioners and researchers in Puerto Rico. This event is part of the company’s broader corporate initiative to foster greater awareness and appreciation in the medical community of established and potential benefits of cannabis and hemp for a range of health and wellness applications. On June 29, 2019, MariMed Hemp, Inc. will sponsor and host an educational and product information seminar for physicians and local industry leaders.
As a Director, he will serve as Chair of MariMed’s Audit Committee. Presently he serves as Chief Financial Officer of True Drinks Holdings, Inc. From September 2018 to May 2019, Mr. Allen served as Chief Financial Officer of Iconic Brands, Inc. Prior to that, from December 2014 to January 2018, Mr. Allen served as the Chief Financial Officer of WPCS International, Inc. From 2007 to 2013, Mr. Allen served as the Chief Financial Officer and Executive Vice President of Administration at Converted Organics, Inc., after serving as audit committee chair on the board of Converted Organics. Mr. Allen is currently an Assistant Professor of Accounting at Southern Connecticut State University (SCSU), a position he has held since 2017.
MariMed Inc. continues to experience the positive fundamental trends in its operating results as reported over the last several quarters, driven by executing its strategic plan for expansion on many fronts in both the cannabis and hemp-based CBD markets. This former director had no involvement in the day to day management or operations of the Company and his departure had been anticipated for some time. The Company is actively looking to replace him and has identified several qualified candidates.
Penelope Finnie, Senior Vice President of Marketing and Branding at MariMed, stated, “Over the past year, MariMed has expanded beyond its advisory service origins with new sales and production facilities, product expansion, strategic acquisitions, key executive hires, and the launch of a wholly-owned subsidiary, MariMed Hemp, focused on hemp-based CBD markets. MariMed, Inc. is dedicated to improving health and wellness with the highest quality hemp and cannabis products. The company offers a full range of cannabis products, operates state of the art cannabis dispensaries in six states, and has a separate division, MariMed Hemp, focused on the development of industrial hemp-derived CBD products.
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /CNW/ - Virtual Investor Conferences, in ...
Public Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , May 14, 2019 /CNW/ - Virtual Investor Conferences, in partnership with Midtown Partners ...
NORWOOD, MA, May 13, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) one of the largest multi-state cannabis operators in the US, today announced 2019 first quarter results for the period ending March 31, 2019. Continued Strong Revenue Growth and Improved Operating Performance - In the first quarter ended March 31, 2019, revenues grew 69% to $3.5 million, compared to $2.1 million for the first quarter of 2018. Gross profit grew 90% to $2.2 million vs. $1.2 million for the first quarter of 2018 compared to the same period in 2018.
NORWOOD, MA, May 09, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) a leading multi-state cannabis and hemp operator in the US, announced today that MariMed CEO Bob Fireman will present at two cannabis investor conferences in New York City, May 14th and 15th. On Wednesday, May 14th, MariMed CEO Bob Fireman will present a company overview at 3:20 PM at the Canaccord Annual Cannabis Conference at the Grand Hyatt in New York City.
MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the US, announced today that its Chief Information Officer, Dr. Jokūbas Žiburkus, will be presenting at the 3rd Institutional Capital & Cannabis Conference held in Los Angeles, CA, May 9-10, 2019. MariMed CEO Bob Fireman noted, “Dr. Žiburkus has long been an innovator and thought leader in research and education on beneficial effects of cannabis compounds for a variety of health conditions.
The Land of Lincoln could soon be the land of legal recreational marijuana -- and these three stocks should be winners as a result.
Marimed Inc (OTCMKTS:MRMD), a major US. hemp and cannabis operator, announced on Thursday that it plans to buy 70% of MediTaurus stake and the transaction will be handled by its MariMed Hemp subsidiary. MediTaurus holds numerous intellectual property patents for cannabis formulations and it also owns the Florance CBD health brand. The latter has a […]The post Marimed To Purchase 70% Of MediTaurus appeared first on Market Exclusive.
MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the U.S., today announced that its MariMed Hemp subsidiary will acquire 70% of MediTaurus, LLC, owner of the international Florance™ brand of CBD health and wellness products and extensive intellectual property (IP) relating to cannabis formulations. This is the first acquisition for MariMed Hemp, which was formed to optimize MariMed’s strategic investment in GenCanna Global, Inc., the Kentucky-based producer of compliant, quality CBD derived from hemp. MediTaurus CEO and Co-founder Dr. Jokūbas Žiburkus will join the MariMed executive team as Chief Innovation Officer and an advisor on scientific research and education.